The researchers tested their hypothesis that a decrease in respiratory virus incidence would be associated with a reduction in inappropriate ambulatory antibiotic orders.
Researchers assessed antibiotic de-escalation practices across hospitals and their associations with outcomes in hospitalized patients with pneumonia who have negative cultures.
A team of researchers sought to identify the incidence, antimicrobial susceptibilities, and outcomes associated with bacterial and fungal secondary infections in a large cohort of patients with COVID-19.
The American College of Physicians convened a panel to identify best practices for the use of short-course antibiotics in the management of common infections.
A team of investigators evaluated penicillin and/or ciprofloxacin resistance among cases of invasive meningococcal disease in the United States.
A retrospective cohort study was conducted to assess tolerability, side effects, and outcomes following treatment with low-dose amikacin in patients with multidrug-resistant tuberculosis.
A team of investigators conducted a multicenter, retrospective, pooled cohort study to assess outcomes following short and prolonged duration of antimicrobial therapy in patients with low risk methicillin-susceptible Staphylococcus aureus bacteremia.
Investigators conducted a retrospective observational study to assess outcomes following treatment with ceftazidime-avibactam for Klebsiella pneumoniae carbapenemase-producing K pneumonia infections.
Carbapenem-resistant Enterobacterales, extended-spectrum β-lactamase-producing Enterobacterales, and Pseudomonas aeruginosa with difficult-to-treat resistance have been designated as urgent or serious threats by the Centers for Disease Control and Prevention.
The authors emphasize that sepsis treatment should be guided by the connection between the microbiota and sepsis outcomes.
